The Health and Social Car Committee will today examine the implications of the Government’s new General Practice Data Planning and Research programme (GPDPR). The session will explore the benefits to medical research and improvements to NHS planning that could be achieved by the Government’s plan to implement a programme of ongoing extraction of GP patient data. The Committee will consider the risks associated with extracting data on this scale such as concerns that confidential health data could be used by marketing or insurance companies and that individual patients may be identifiable despite processes which are intended to prevent this from happening. The hearing will also examine the extent to which patients understand how their data is used by the NHS, the strength of the opt-out options available to patients, and parallels with the care.data scheme which was closed in 2016.